Cargando…

Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects

BACKGROUND: Whether the single nucleotide polymorphism (SNP) Lys751Gln of xeroderma pigmentosum group D(XPD) gene increases susceptibility to head and neck cancer (HNC) is controversial and undetermined. Therefore, we conducted this meta-analysis to systematically assess the possible association bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hai, Lin, Dong, Zheng, Chunquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916081/
https://www.ncbi.nlm.nih.gov/pubmed/24443924
http://dx.doi.org/10.1186/1746-1596-9-15
_version_ 1782302663512162304
author Lin, Hai
Lin, Dong
Zheng, Chunquan
author_facet Lin, Hai
Lin, Dong
Zheng, Chunquan
author_sort Lin, Hai
collection PubMed
description BACKGROUND: Whether the single nucleotide polymorphism (SNP) Lys751Gln of xeroderma pigmentosum group D(XPD) gene increases susceptibility to head and neck cancer (HNC) is controversial and undetermined. Therefore, we conducted this meta-analysis to systematically assess the possible association between them. METHODS: The OVID, Medline, Embase, Pubmed, Web of Science databases were searched to identify the eligible studies. The odds ratio (OR) with 95% confidence interval (95% CI) were used to assess the strength of association. RESULTS: A total of 11,443 subjects from eighteen studies were subjected to meta-analysis. Overall, XPD Lys751Gln polymorphism had no association with increased HNC risk under all five genetic models (P > 0.05). In the subgroup analysis by ethnicity and source of controls, still no significant association was found under five genetic models (P > 0.05). In the subgroup analysis by cancer type, XPD Lys751Gln polymorphism had statistically significant association with elevated laryngeal cancer (LC) and nasopharyngeal cancer (NPC) risk under heterozygous comparison and dominant model (P<0.05) and borderline significantly increased risk was found under allele contrast for LC and NPC. Carriers of Lys allele and Lys/Lys genotype may be associated with elevated LC and NPC risk. CONCLUSIONS: There is overall lack of association between XPD Lys751Gln polymorphism and HNC risk under all five genetic models and still no significant association was found in the subgroup analysis by ethnicity and source of controls. However, XPD Lys751Gln polymorphism was significantly associated with susceptibility to LC and NPC and the Lys allele and Lys/Lys genotype of XPD Lys751Gln polymorphism may be a risk factor for LC and NPC. However, relatively modest sample sizes were included in this meta-analysis and studies with large sample sizes and representative population are warranted to further clarify this finding. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/5628716106316015.
format Online
Article
Text
id pubmed-3916081
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39160812014-02-07 Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects Lin, Hai Lin, Dong Zheng, Chunquan Diagn Pathol Research BACKGROUND: Whether the single nucleotide polymorphism (SNP) Lys751Gln of xeroderma pigmentosum group D(XPD) gene increases susceptibility to head and neck cancer (HNC) is controversial and undetermined. Therefore, we conducted this meta-analysis to systematically assess the possible association between them. METHODS: The OVID, Medline, Embase, Pubmed, Web of Science databases were searched to identify the eligible studies. The odds ratio (OR) with 95% confidence interval (95% CI) were used to assess the strength of association. RESULTS: A total of 11,443 subjects from eighteen studies were subjected to meta-analysis. Overall, XPD Lys751Gln polymorphism had no association with increased HNC risk under all five genetic models (P > 0.05). In the subgroup analysis by ethnicity and source of controls, still no significant association was found under five genetic models (P > 0.05). In the subgroup analysis by cancer type, XPD Lys751Gln polymorphism had statistically significant association with elevated laryngeal cancer (LC) and nasopharyngeal cancer (NPC) risk under heterozygous comparison and dominant model (P<0.05) and borderline significantly increased risk was found under allele contrast for LC and NPC. Carriers of Lys allele and Lys/Lys genotype may be associated with elevated LC and NPC risk. CONCLUSIONS: There is overall lack of association between XPD Lys751Gln polymorphism and HNC risk under all five genetic models and still no significant association was found in the subgroup analysis by ethnicity and source of controls. However, XPD Lys751Gln polymorphism was significantly associated with susceptibility to LC and NPC and the Lys allele and Lys/Lys genotype of XPD Lys751Gln polymorphism may be a risk factor for LC and NPC. However, relatively modest sample sizes were included in this meta-analysis and studies with large sample sizes and representative population are warranted to further clarify this finding. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/5628716106316015. BioMed Central 2014-01-20 /pmc/articles/PMC3916081/ /pubmed/24443924 http://dx.doi.org/10.1186/1746-1596-9-15 Text en Copyright © 2014 Lin et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lin, Hai
Lin, Dong
Zheng, Chunquan
Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects
title Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects
title_full Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects
title_fullStr Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects
title_full_unstemmed Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects
title_short Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects
title_sort association of xpd lys751gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916081/
https://www.ncbi.nlm.nih.gov/pubmed/24443924
http://dx.doi.org/10.1186/1746-1596-9-15
work_keys_str_mv AT linhai associationofxpdlys751glnpolymorphismwithheadandneckcancersusceptibilityevidencefrom11443subjects
AT lindong associationofxpdlys751glnpolymorphismwithheadandneckcancersusceptibilityevidencefrom11443subjects
AT zhengchunquan associationofxpdlys751glnpolymorphismwithheadandneckcancersusceptibilityevidencefrom11443subjects